Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019

This cross-sectional study uses direct pharmaceutical claims data from a commercial claims database to assess the use of 6 types of immunosuppressive drugs among commercially insured US adults in 2018 and 2019.

Detalles Bibliográficos
Autores principales: Wallace, Beth I., Kenney, Brooke, Malani, Preeti N., Clauw, Daniel J., Nallamothu, Brahmajee K., Waljee, Akbar K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138687/
https://www.ncbi.nlm.nih.gov/pubmed/34014329
http://dx.doi.org/10.1001/jamanetworkopen.2021.4920
_version_ 1783695860363689984
author Wallace, Beth I.
Kenney, Brooke
Malani, Preeti N.
Clauw, Daniel J.
Nallamothu, Brahmajee K.
Waljee, Akbar K.
author_facet Wallace, Beth I.
Kenney, Brooke
Malani, Preeti N.
Clauw, Daniel J.
Nallamothu, Brahmajee K.
Waljee, Akbar K.
author_sort Wallace, Beth I.
collection PubMed
description This cross-sectional study uses direct pharmaceutical claims data from a commercial claims database to assess the use of 6 types of immunosuppressive drugs among commercially insured US adults in 2018 and 2019.
format Online
Article
Text
id pubmed-8138687
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-81386872021-06-01 Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019 Wallace, Beth I. Kenney, Brooke Malani, Preeti N. Clauw, Daniel J. Nallamothu, Brahmajee K. Waljee, Akbar K. JAMA Netw Open Research Letter This cross-sectional study uses direct pharmaceutical claims data from a commercial claims database to assess the use of 6 types of immunosuppressive drugs among commercially insured US adults in 2018 and 2019. American Medical Association 2021-05-20 /pmc/articles/PMC8138687/ /pubmed/34014329 http://dx.doi.org/10.1001/jamanetworkopen.2021.4920 Text en Copyright 2021 Wallace BI et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Wallace, Beth I.
Kenney, Brooke
Malani, Preeti N.
Clauw, Daniel J.
Nallamothu, Brahmajee K.
Waljee, Akbar K.
Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
title Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
title_full Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
title_fullStr Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
title_full_unstemmed Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
title_short Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
title_sort prevalence of immunosuppressive drug use among commercially insured us adults, 2018-2019
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138687/
https://www.ncbi.nlm.nih.gov/pubmed/34014329
http://dx.doi.org/10.1001/jamanetworkopen.2021.4920
work_keys_str_mv AT wallacebethi prevalenceofimmunosuppressivedruguseamongcommerciallyinsuredusadults20182019
AT kenneybrooke prevalenceofimmunosuppressivedruguseamongcommerciallyinsuredusadults20182019
AT malanipreetin prevalenceofimmunosuppressivedruguseamongcommerciallyinsuredusadults20182019
AT clauwdanielj prevalenceofimmunosuppressivedruguseamongcommerciallyinsuredusadults20182019
AT nallamothubrahmajeek prevalenceofimmunosuppressivedruguseamongcommerciallyinsuredusadults20182019
AT waljeeakbark prevalenceofimmunosuppressivedruguseamongcommerciallyinsuredusadults20182019

Ejemplares similares